Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
Drexel H, Tamargo J, Kaski JC, Lewis BS, Saely CH, Fraunberger P, Dobrev D, Komiyama M, Plattner T, Agewall S, Hasegawa K.
Drexel H, et al. Among authors: hasegawa k.
Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):570-582. doi: 10.1093/ehjcvp/pvad044.
Eur Heart J Cardiovasc Pharmacother. 2023.
PMID: 37328424
Review.